vs

Side-by-side financial comparison of Baldwin Insurance Group, Inc. (BWIN) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

Baldwin Insurance Group, Inc. is the larger business by last-quarter revenue ($347.3M vs $197.9M, roughly 1.8× REPLIGEN CORP). REPLIGEN CORP runs the higher net margin — 6.7% vs -7.5%, a 14.2% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 5.3%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $-68.9M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs -4.4%).

The Baldwin Piano Company is an American piano brand. It was once the largest US-based manufacturer of keyboard instruments and was known by the slogan, "America's Favorite Piano". Since 2001, it has been a subsidiary of Gibson Brands, Inc. Baldwin ceased domestic production in December 2008, moving its piano manufacturing to China.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

BWIN vs RGEN — Head-to-Head

Bigger by revenue
BWIN
BWIN
1.8× larger
BWIN
$347.3M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+8.4% gap
RGEN
13.6%
5.3%
BWIN
Higher net margin
RGEN
RGEN
14.2% more per $
RGEN
6.7%
-7.5%
BWIN
More free cash flow
RGEN
RGEN
$86.5M more FCF
RGEN
$17.6M
$-68.9M
BWIN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
-4.4%
BWIN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BWIN
BWIN
RGEN
RGEN
Revenue
$347.3M
$197.9M
Net Profit
$-25.9M
$13.3M
Gross Margin
52.5%
Operating Margin
-3.8%
9.0%
Net Margin
-7.5%
6.7%
Revenue YoY
5.3%
13.6%
Net Profit YoY
-28.3%
143.9%
EPS (diluted)
$-0.38
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BWIN
BWIN
RGEN
RGEN
Q4 25
$347.3M
$197.9M
Q3 25
$365.4M
$188.8M
Q2 25
$378.8M
$182.4M
Q1 25
$413.4M
$169.2M
Q4 24
$329.9M
$174.1M
Q3 24
$338.9M
$154.9M
Q2 24
$339.8M
$154.1M
Q1 24
$380.4M
$151.3M
Net Profit
BWIN
BWIN
RGEN
RGEN
Q4 25
$-25.9M
$13.3M
Q3 25
$-18.7M
$14.9M
Q2 25
$-3.2M
$14.9M
Q1 25
$13.9M
$5.8M
Q4 24
$-20.2M
$-30.3M
Q3 24
$-8.4M
$-654.0K
Q2 24
$-17.6M
$3.3M
Q1 24
$21.6M
$2.1M
Gross Margin
BWIN
BWIN
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
BWIN
BWIN
RGEN
RGEN
Q4 25
-3.8%
9.0%
Q3 25
0.9%
8.9%
Q2 25
7.4%
7.6%
Q1 25
13.6%
3.9%
Q4 24
-1.7%
-17.7%
Q3 24
4.5%
-5.1%
Q2 24
4.8%
1.0%
Q1 24
9.0%
1.3%
Net Margin
BWIN
BWIN
RGEN
RGEN
Q4 25
-7.5%
6.7%
Q3 25
-5.1%
7.9%
Q2 25
-0.8%
8.2%
Q1 25
3.4%
3.4%
Q4 24
-6.2%
-17.4%
Q3 24
-2.5%
-0.4%
Q2 24
-5.2%
2.2%
Q1 24
5.7%
1.4%
EPS (diluted)
BWIN
BWIN
RGEN
RGEN
Q4 25
$-0.38
$0.24
Q3 25
$-0.27
$0.26
Q2 25
$-0.05
$0.26
Q1 25
$0.20
$0.10
Q4 24
$-0.31
$-0.55
Q3 24
$-0.13
$-0.01
Q2 24
$-0.28
$0.06
Q1 24
$0.33
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BWIN
BWIN
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$123.7M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$600.2M
$2.1B
Total Assets
$3.9B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BWIN
BWIN
RGEN
RGEN
Q4 25
$123.7M
$767.6M
Q3 25
$89.7M
$748.7M
Q2 25
$105.7M
$708.9M
Q1 25
$81.8M
$697.2M
Q4 24
$90.0M
$757.4M
Q3 24
$181.8M
$784.0M
Q2 24
$208.3M
$809.1M
Q1 24
$112.1M
$780.6M
Total Debt
BWIN
BWIN
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BWIN
BWIN
RGEN
RGEN
Q4 25
$600.2M
$2.1B
Q3 25
$619.7M
$2.1B
Q2 25
$630.8M
$2.1B
Q1 25
$619.6M
$2.0B
Q4 24
$583.2M
$2.0B
Q3 24
$595.4M
$2.0B
Q2 24
$590.9M
$2.0B
Q1 24
$597.9M
$2.0B
Total Assets
BWIN
BWIN
RGEN
RGEN
Q4 25
$3.9B
$2.9B
Q3 25
$3.8B
$2.9B
Q2 25
$3.7B
$2.9B
Q1 25
$3.5B
$2.9B
Q4 24
$3.5B
$2.8B
Q3 24
$3.5B
$2.8B
Q2 24
$3.7B
$2.9B
Q1 24
$3.5B
$2.8B
Debt / Equity
BWIN
BWIN
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BWIN
BWIN
RGEN
RGEN
Operating Cash FlowLast quarter
$-29.4M
$25.7M
Free Cash FlowOCF − Capex
$-68.9M
$17.6M
FCF MarginFCF / Revenue
-19.9%
8.9%
Capex IntensityCapex / Revenue
11.4%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$-137.8M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BWIN
BWIN
RGEN
RGEN
Q4 25
$-29.4M
$25.7M
Q3 25
$41.0M
$48.1M
Q2 25
$-16.7M
$28.6M
Q1 25
$-64.0M
$15.0M
Q4 24
$51.5M
$39.2M
Q3 24
$32.4M
$49.3M
Q2 24
$18.3M
$42.2M
Q1 24
$3.0M
$44.7M
Free Cash Flow
BWIN
BWIN
RGEN
RGEN
Q4 25
$-68.9M
$17.6M
Q3 25
$32.2M
$43.4M
Q2 25
$-28.1M
$21.5M
Q1 25
$-72.9M
$11.4M
Q4 24
$10.4M
$33.6M
Q3 24
$22.2M
$42.3M
Q2 24
$7.8M
$37.4M
Q1 24
$-5.1M
$36.4M
FCF Margin
BWIN
BWIN
RGEN
RGEN
Q4 25
-19.9%
8.9%
Q3 25
8.8%
23.0%
Q2 25
-7.4%
11.8%
Q1 25
-17.6%
6.8%
Q4 24
3.2%
19.3%
Q3 24
6.6%
27.3%
Q2 24
2.3%
24.3%
Q1 24
-1.4%
24.0%
Capex Intensity
BWIN
BWIN
RGEN
RGEN
Q4 25
11.4%
4.1%
Q3 25
2.4%
2.5%
Q2 25
3.0%
3.9%
Q1 25
2.2%
2.1%
Q4 24
12.4%
3.2%
Q3 24
3.0%
4.5%
Q2 24
3.1%
3.1%
Q1 24
2.1%
5.5%
Cash Conversion
BWIN
BWIN
RGEN
RGEN
Q4 25
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
-4.59×
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
0.14×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BWIN
BWIN

Insurance Advisory Solutions$157.9M45%
Underwriting Capacity Technology Solutions$129.5M37%
Consultingand Service Fee Revenue$20.9M6%
Policy Feeand Installment Fee Revenue$20.4M6%
Other$7.3M2%
Earned Premium$6.9M2%
Other Insurance Product Line$4.4M1%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons